Past Forum 2017

First Look: The Next Wave of Cardiology Breakthroughs

Discovery Café Breakout Sessions: Sharing Perspectives

Opening Remarks

• Introducer: Anne Klibanski, MD, Chief Academic Officer, Partners HealthCare; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, Harvard Medical School
• David Torchiana, MD, CEO, Partners HealthCare

Reinventing Cardiac Care

• Calum MacRae, MD, PhD, Chief of Cardiovascular Medicine, BWH; Associate Professor of Medicine,Harvard Medical School
• Anthony Rosenzweig, MD, Chief, Cardiology Division, MGH; Professor of Medicine, Harvard Medical School

CEO Roundtable: Today’s Learning, Tomorrow’s Opportunities

• Moderator: Benjamin Pless, Executive in Residence, Partners HealthCare Innovation
• John Flannery, CEO, GE Healthcare
• Michael Minogue, CEO, Abiomed
• Michael Mussallem, CEO, Edwards Lifesciences
• Timothy Ring, CEO, Bard
• Lewis Sandy, MD, EVP, Clinical Advancement, UnitedHealth Group

Tackling the AFib Epidemic

• Moderator: Jagmeet Singh, MD, DPhil, Associate Chief, Cardiology Division, MGH Heart Center; Professor of Medicine, Harvard Medical School
• Patrick Ellinor, MD, PhD, Director, Cardiac Arrhythmia Service, MGH; Associate Professor, Harvard Medical School
• Colleen Fowler, VP, GM, AF Solutions, Medtronic
• Parashar Patel, VP, Global Health Policy, Boston Scientific
• Michael Rousseau, President, Cardiovascular and Neuromodulation, Abbott
• Steven Zelenkofske, DO, VP US Medical Affairs, CVMD TA, AstraZeneca

1:1 Fireside Chat: Omar Ishrak, PhD, CEO, Medtronic

• Moderator: Paul LaViolette, Managing Partner & COO, SV Life Sciences Advisers
• Omar Ishrak, PhD, CEO, Medtronic

Heart Failure’s Therapeutic Mandate

• Moderator: Akshay Desai, MD, Director, Heart Failure Disease Management, BWH; Associate Professor, Harvard Medical School
• Philip Adamson, MD, VP and Medical Director, Abbott
• Craig Basson, MD, PhD, VP, Global Translational Medicine Head (CVM), Novartis Institutes for BioMedical Research; Senior Lecturer, Harvard Medical School
• Marc Semigran, MD, CMO, Myokardia
• Kenneth Stein, MD SVP, CMO, Global Health Policy, Rhythm Management, Boston Scientific

CLINICAL HIGHLIGHT: A New Chapter of PAD

• Moderator: Michael Jaff, DO, President, Newton-Wellesley Hospital, Partners HealthCare; Professor of Medicine, Harvard Medical School
• Douglas Drachman, MD, Director, Cardiology and Interventional Cardiology Fellowship Programs, MGH; Assistant Professor of Medicine, Harvard Medical School
• Tamara Syrek Jensen, Director, Coverage and Analysis Group, CMS
• Misti Malone, PhD, Chief, Peripheral Interventional Devices Branch, Food and Drug Administration
• Shaden Marzouk, MD, CMO, Cardinal Health
• Matthew Menard, MD, Co-Director, Endovascular Surgery, BWH; Assistant Professor, Harvard Medical School
• Jeff Mirviss, SVP and President, Peripheral Interventions, Boston Scientific

FOCUS SESSION: Japan Today: Advancing Cardiometabolic Therapies

• Moderator: Masanori Aikawa, MD, PhD, Yoshiro Miwa Associate Chair and Founding Director, Center for Interdisciplinary Cardiovascular Sciences, BWH
• Carsten Brunn, PhD, Head of Pharmaceuticals, Americas Region, Bayer
• Hiroyuki Kawabata, Director, Health & Welfare Department, JETRO New York
• Makoto Suematsu, MD, PhD, President, Japan Agency for Medical Research and Development
• Eiji Tanaka, PhD, President, Head of Global Business Development, Mitsubishi Tanabe Pharma Holdings America, Inc.

Pricing to Enable Affordability and Innovation

• Moderator: Peter Slavin, MD, President, MGH
• Katrina Armstrong, MD, Physician-in-Chief, Department of Medicine, MGH; Jackson Professor of Clinical Medicine, Harvard Medical School
• George Barrett, CEO, Cardinal Health
• Paul Fonteyne, CEO, Boehringer Ingelheim USA
• Robert Ford, EVP, Medical Devices, Abbott
• Benjamin Scirica, MD, Director of Innovation, Cardiovascular Division, Senior Investigator, TIMI Study Group, BWH; Associate Professor of Medicine, Harvard Medical School

CLINICAL HIGHLIGHT: Emerging Devices for Complex Structural Heart Disease

• Moderator: Jason Mills, Managing Director, Head of US Healthcare Research, Canaccord Genuity
• Michael Dale, Divisional Vice President and General Manager, Structural Heart, Abbott
• Ian Meredith, PhD, EVP, Global CMO, Boston Scientific
• Patrick O’Gara, MD, Director, Clinical Cardiology, Executive Medical Director, BWH; Professor of Medicine, Harvard Medical School
• Stanton Rowe, CVP, Advanced Technology, CSO, Edwards Lifesciences
• Sean Salmon, SVP and President, Coronary & Structural Heart, Medtronic

1:1 Fireside Chat: John Lechleiter, PhD, Chairman, Eli Lilly

• Moderator: Susan Dentzer, CEO, Network for Excellence in Health Innovation
• John Lechleiter, PhD, Chairman, Eli Lilly and Company

Personal Monitoring for Disease Management

• Moderator: Joe Kvedar, MD, VP, Connected Health, Partners HealthCare; Associate Professor of Dermatology, Harvard Medical School
• Adam Landman, MD, CIO, VP, BWH; Course Co-Director, Harvard Medical School
• Michael Reitermann, COO, Siemens Healthineers
• Jonathan Rennert, CEO, Zoll Medical
• Stanley Shaw, MD, PhD, CSO, One Brave Idea, BWH; Associate Dean for Executive Education, Harvard Medical School

1:1 Fireside Chat: Robert Bradway, CEO, Amgen

• Moderator: Scott Sperling, Co-President, Thomas H Lee Partners
• Robert Bradway, CEO, Amgen

Austen-Braunwald Award

• Brigham and Women’s Hospital Winner: Benjamin Olenchock, MD, PhD, Cardiovascular Medicine Specialist, BWH; Instructor in Medicine, Harvard Medical School
• Massachusetts General Hospital Winner:
  Steven Lubitz, MD, Cardiac Electrophysiologist, MGH; Assistant Professor of Medicine, Harvard Medical School

Global Clinical Trials: Next Generation Design and Scalability

• Moderator: Marc Sabatine, MD, Chairman, TIMI Study Group, Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine, BWH
• Elisabeth Björk, MD, PhD, VP, Cardiovascular & Metabolic Disease Head, Global Medicines Development, AstraZeneca
• Daniel Bloomfield, MD, SVP, Global Clinical Research, Therapeutic Area Head, Cardiometabolic & Womens Health, MRL Lead, China R&D, Merck
• Jonathan Plehn, MD, VP Cardiovascular Medicine, Covance
• Norman Stockbridge, MD, PhD, Director, Division of Cardiovascular and Renal Products, Food and Drug Administration
• Scott Wasserman, MD, VP, Global Development, Amgen

Precision Cardiovascular Medicine: What is Different This Time

• Moderator: Alex de Winter, PhD, Managing Director, GE Ventures
• Sean Harper, MD, EVP, R&D, Amgen
• Kevin Hrusovsky, CEO, Quanterix
• Dean Li, MD, PhD, VP, Head Translational Medicine, Merck
• David Milan, MD, Assistant in Medicine, MGH; Assistant Professor, Harvard Medical School
• Christine Seidman, MD, Director, Cardiovascular Genetics Center, BWH; Thomas W. Smith Professor

CV Investing in the Next Decade

• Moderator: Meg Tirrell, Reporter, CNBC
• Leslie Bottorff, Managing Director, Healthcare, GE Ventures
• Jean-François Formela, MD, Partner, Atlas Venture
• Bob Hopkins, Managing Director, US Medical Technology, Equity Research, Bank of America Merrill Lynch
• Roger Kitterman, VP, Venture, Partners HealthCare
• James Topper, MD, PhD, Managing General Partner, Frazier Healthcare Partners

CLINICAL HIGHLIGHT: Optimizing Care for the 51%: New Market Opportunities

• Moderator: Cathy Minehan, Managing Director, Arlington Advisory Partners
• Nancy Brown, CEO, American Heart Association
• Christine Albert, MD, Center for Arrhythmia Prevention, BWH; Professor of Medicine, Harvard Medical School
• Adele Gulfo, EVP & Head, Global Commercial Development, Mylan
• Allison Kean, MD, CV Therapeutic Area Lead, Global Business Development, Pfizer
• Paul Underwood, MD, Medical Director, Boston Scientific
• Malissa Wood, MD, Co-Director, MGH Heart Center Corrigan Women’s

Disruptive Therapeutic Platforms: New Tools, New Outcomes

• Moderator: Tony Coles, MD, CEO, Yumanity Therapeutics
• Stéphane Bancel, CEO, Moderna
• Katrine Bosley, CEO, Editas Medicine
• Mark Cobbold, MD, PhD, Center for Cancer Immunology, MGH; Member of the Faculty of Medicine, Harvard Medical School
• John Maraganore, PhD, CEO, Alnylam
• Ryuichi Morishita, MD, PhD, Founder, AnGes

1:1 Fireside Chat: Robert Califf, MD, Commissioner (former), FDA

• Moderator: Joseph Loscalzo, MD, PhD, Chairman, Department of Medicine, Physician-in-Chief, BWH; Hersey Professor of the Theory and Practice of Medicine, Soma Weiss, MD Distinguished Chair in Medicine, Harvard Medical School
• Robert Califf, MD, Commissioner (former), Food and Drug Administration

Innovation in Translational Trials

• Moderator: Mason Freeman, MD, Director, Translational Research Center, MGH; Professor of Medicine, Harvard Medical School
• Seigo Izumo, MD, SVP, Global Head of Regenerative Medicine Unit, Head of Scientific Affairs, Japan, Takeda
• John Lepore, MD, SVP, R&D Pipeline, GlaxoSmithKline
• Jessica Mega, MD, CMO, Verily
• Alan Moses, MD, SVP, Global CMO, Novo Nordisk
• Sy Pretorius, MD, SVP & CSO, PAREXEL International

1:1 Fireside Chat: Michael Mahoney, CEO, Boston Scientific

• Introducer: Edward Lawrence, Chairman, Board of Directors, Partners HealthCare; Retired Partner, Ropes & Gray
• Meg Tirrell, Reporter, CNBC
• Michael Mahoney, CEO, Boston Scientific

New Targets in Coronary Artery Disease

• Moderator: Sekar Kathiresan, MD, Director, Center for Human Genetic Research, MGH; Associate Professor of Medicine, Harvard Medical School
• Aarif Khakoo, MD, VP Research, Cardiometabolic Disorders Therapeutic Area Head, Site Head Amgen San Francisco, Amgen
• Clive Meanwell, MD, PhD, CEO, The Medicines Company
• Paul Ridker, MD, Director, Center for Cardiovascular Disease Prevention, BWH; Eugene Braunwald Professor of Medicine, Harvard Medical School
• Craig Sponseller, MD, CMO, Kowa Pharmaceuticals

1:1 Fireside Chat: Gary Gibbons, MD, NHLBI

• Moderator: Elizabeth Nabel, MD, President, Brigham Health; Professor of Medicine, Harvard Medical School
• Gary Gibbons, MD, Director, NHLBI

The Skinny on Fat: Therapeutic Opportunities

• Moderator: Ora Pescovitz, MD, SVP and US Medical Leader, Eli Lilly and Company
• Morris Birnbaum, MD, PhD, SVP and CSO, CVMET, Pfizer
• Ludovic Helfgott, Global VP, Cardiovascular, Renal and Metabolism, AstraZeneca
• Thomas Hughes, PhD, CEO, Zafgen
• Lee Kaplan, MD, PhD, Director, Obesity, Metabolism & Nutrition Institute, MGH; Associate Professor, Harvard Medical School
• Bruce Spiegelman, PhD, Stanley J. Korsmeyer Professor of Cell Biology and Medicine, Dana-Farber Cancer Institute, Harvard Medical School